Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2025 02:00 ET | Source: T-Therapeutics

T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics towards the clinic

$32 million new equity injection adds to previously announced $59 millionNew investors Tencent and BGF joined by all existing major shareholdersFunds will advance pipeline of novel TCR-CD3...